Exploiting Subsite S1 of Trypsin-Like Serine Proteases for Selectivity: Potent and Selective Inhibitors of Urokinase-Type Plasminogen Activator
- 6 October 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (23) , 3856-3871
- https://doi.org/10.1021/jm010244+
Abstract
A nonselective inhibitor of trypsin-like serine proteases, 2-(2-hydroxybiphenyl-3-yl)-1H-indole-5-carboxamidine (1) (Verner, E.; Katz, B. A.; Spencer, J.; Allen, D.; Hataye, J.; Hruzewicz, W.; Hui, H. C.; Kolesnikov, A.; Li, Y.; Luong, C.; Martelli, A.; Radika. K.; Rai, R.; She, M.; Shrader, W.; Sprengeler, P. A.; Trapp, S.; Wang, J.; Young, W. B.; Mackman, R. L. J. Med. Chem.2001, 44, 2753−2771) has been optimized through minor structural changes on the S1 binding group to afford remarkably selective and potent inhibitors of urokinase-type plasminogen activator (uPA). The trypsin-like serine proteases1 that comprise drug targets can be broadly categorized into two subfamilies, those with Ser190 and those with Ala190. A single-atom modification, for example, replacement of hydrogen for chlorine at the 6-position of the 5-amidinoindole P1 group on 1, generated up to 6700-fold selectivity toward the Ser190 enzymes and against the Ala190 enzymes. The larger chlorine atom displaces a water molecule (H2O1S1) that binds near residue 190 in all the complexes of 1, and related inhibitors, in uPA, thrombin, and trypsin. The water molecule, H2O1S1, in both the Ser190 or Ala190 enzymes, hydrogen bonds with the amidine N1 nitrogen of the inhibitor. When it is displaced, a reduction in affinity toward the Ala190 enzymes is observed due to the amidine N1 nitrogen of the bound inhibitor being deprived of a key hydrogen-bonding partner. In the Ser190 enzymes the affinity is maintained since the serine hydroxyl oxygen OγSer190 compensates for the displaced water molecule. High-resolution crystallography provided evidence for the displacement of the water molecule and validated the design rationale. In summation, a novel and powerful method for engineering selectivity toward Ser190 proteases and against Ala190 proteases without substantially increasing molecular weight is described.Keywords
This publication has 22 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode: Inhibitors of Urokinase-Type Plasminogen Activator and Factor XaJournal of Medicinal Chemistry, 2001
- Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug designJournal of Molecular Biology, 2000
- A Palladium-Catalyzed Strategy for the Preparation of Indoles: A Novel Entry into the Fischer Indole SynthesisJournal of the American Chemical Society, 1998
- X-ray Structure of Active Site-inhibited Clotting Factor XaPublished by Elsevier ,1996
- The Entropic Cost of Bound Water in Crystals and BiomoleculesScience, 1994
- Regioselective Cleavage Reaction of the Aromatic Methylenedioxy Ring. V. Cleavage with Sodium Alkoxides - Alcohols, Potassium tert-Butoxide - Alcohols, Dimsyl Anion - Methyl Alcohol, Metallic Sodium - Alcohols, and Sodium Cyanide in Dipolar Aprotic Solvents.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- New methodology for the synthesis of functionalized indolizidine and quinolizidine ring systemsJournal of the American Chemical Society, 1991
- Substrate specificity of tissue-type and urokinase-type plasminogen activatorsBiochemical and Biophysical Research Communications, 1991
- Synthesis of isoesteres of p-amidinophenylpyruvic acid. Inhibitors of trypsin, thrombin, and pancreatic kallikreinJournal of Medicinal Chemistry, 1975